Nothing Special   »   [go: up one dir, main page]

DE3583803D1 - Rhodanin-derivate und verfahren zu deren herstellung. - Google Patents

Rhodanin-derivate und verfahren zu deren herstellung.

Info

Publication number
DE3583803D1
DE3583803D1 DE8585309401T DE3583803T DE3583803D1 DE 3583803 D1 DE3583803 D1 DE 3583803D1 DE 8585309401 T DE8585309401 T DE 8585309401T DE 3583803 T DE3583803 T DE 3583803T DE 3583803 D1 DE3583803 D1 DE 3583803D1
Authority
DE
Germany
Prior art keywords
production
rhodanine derivatives
rhodanine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585309401T
Other languages
English (en)
Inventor
Kazuo Ogawa
Takaji Honna
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3583803D1 publication Critical patent/DE3583803D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
DE8585309401T 1985-07-10 1985-12-23 Rhodanin-derivate und verfahren zu deren herstellung. Expired - Fee Related DE3583803D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60152632A JPS6212776A (ja) 1985-07-10 1985-07-10 ロ−ダニン誘導体

Publications (1)

Publication Number Publication Date
DE3583803D1 true DE3583803D1 (de) 1991-09-19

Family

ID=15544630

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585309401T Expired - Fee Related DE3583803D1 (de) 1985-07-10 1985-12-23 Rhodanin-derivate und verfahren zu deren herstellung.

Country Status (8)

Country Link
US (2) US4714765A (de)
EP (2) EP0258914A3 (de)
JP (1) JPS6212776A (de)
KR (1) KR910006638B1 (de)
AU (1) AU556518B1 (de)
CA (1) CA1264758A1 (de)
DE (1) DE3583803D1 (de)
ES (1) ES8704486A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI91869C (fi) * 1987-03-18 1994-08-25 Tanabe Seiyaku Co Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi
US4897406A (en) * 1987-11-13 1990-01-30 Nisshin Flour Milling Co., Ltd. Rhodanine derivatives and pharmaceutical compositions
JP2835545B2 (ja) * 1990-11-27 1998-12-14 株式会社大塚製薬工場 白内障予防及び治療剤
JP2835547B2 (ja) * 1991-12-25 1998-12-14 株式会社大塚製薬工場 糖尿病治療剤
NZ248573A (en) * 1992-09-10 1996-02-27 Lilly Co Eli 5-arylmethyl (and methylidene) thiazolidin-4-one derivatives; their preparation and pharmaceutical compositions
US6251928B1 (en) 1994-03-16 2001-06-26 Eli Lilly And Company Treatment of alzheimer's disease employing inhibitors of cathepsin D
DK0848004T3 (da) * 1995-07-31 2003-07-21 Shionogi & Co Pyrrolidinderivater med inhiberende aktivitet mod phospholipase A2
WO2000018747A1 (en) * 1998-09-30 2000-04-06 Roche Diagnostics Gmbh Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders
US7022725B2 (en) 2000-11-17 2006-04-04 Takeda Pharmaceutical Company Limited Isoxazole derivatives
KR101095734B1 (ko) 2009-01-23 2011-12-21 숙명여자대학교산학협력단 신규한 로다닌 유도체와 이의 의약적 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB489335A (en) * 1937-01-22 1938-07-22 Douglas James Fry Improvements in or relating to the manufacture and use of dyestuffs suitable for sensitising photographic emulsions
SU467058A1 (ru) * 1973-09-20 1975-04-15 Московский Ордена Трудового Красного Знамени Институт Нефтехимической И Газовой Промышленности Им.И.М.Губкина Способ получени смеси бисфенолов
JPS5430171A (en) * 1977-08-10 1979-03-06 Taiho Pharmaceutical Co Ltd Isooxazole derivative and production
JPS5728074A (en) 1980-07-28 1982-02-15 Ono Pharmaceut Co Ltd Rhodanine derivative, its preparation, and inhibitor for aldose reducing enzyme consisting essentially of it
JPS5740478A (en) * 1980-08-22 1982-03-06 Ono Pharmaceut Co Ltd Rhodanine derivative, its preparation and aldose reductase inhibitor containing rhodanine derivative
JPS6127984A (ja) * 1984-07-16 1986-02-07 Taiho Yakuhin Kogyo Kk ロ−ダニン酢酸誘導体
JPH0638665B2 (ja) * 1985-07-08 1994-05-18 松下電器産業株式会社 リニア信号処理回路

Also Published As

Publication number Publication date
EP0208040B1 (de) 1991-08-14
AU556518B1 (en) 1986-11-06
KR870001204A (ko) 1987-03-12
JPH0574591B2 (de) 1993-10-18
JPS6212776A (ja) 1987-01-21
EP0258914A3 (de) 1988-11-17
EP0258914A2 (de) 1988-03-09
EP0208040A3 (en) 1988-03-16
CA1266273C (de) 1990-02-27
US4714765A (en) 1987-12-22
CA1264758A1 (en) 1990-01-23
KR910006638B1 (ko) 1991-08-29
US4777259A (en) 1988-10-11
EP0208040A2 (de) 1987-01-14
ES8704486A1 (es) 1987-04-16
ES551410A0 (es) 1987-04-16

Similar Documents

Publication Publication Date Title
DE3577552D1 (de) Vitamin d-derivate und verfahren zu deren herstellung.
DE3682575D1 (de) Eingebettete flachretroreflektive beschichtung und verfahren zu deren herstellung.
DE3680859D1 (de) Chinolinderivate und verfahren zu deren herstellung.
DE3682874D1 (de) Pyranoindolizinderivate und verfahren zu ihrer herstellung.
DE3675741D1 (de) Vernetzte copolyamidimide und verfahren zu deren herstellung.
DE3586822D1 (de) Halbleiteranordnung und verfahren zu deren herstellung.
DE3684085D1 (de) Reinigungsmittelzusammensetzung und verfahren zu deren herstellung.
DE3582576D1 (de) Dithioketo-pyrrolo-pyrrole, verfahren zu deren herstellung und verwendung.
DE3780560D1 (de) Fuehler und verfahren zu dessen herstellung.
DE3769400D1 (de) Verkapselte halbleiteranordnung und verfahren zu deren herstellung.
DE68907057D1 (de) Naehrstoffzusammensetzung und verfahren zu deren herstellung.
DE3483225D1 (de) Waesserige atelocollagen-loesung und verfahren zu deren herstellung.
DE3688604D1 (de) Optisches geraet und verfahren zu dessen herstellung.
DE3785163D1 (de) 3-pyrrolidinylthio-1-azabicyclo(3.2.0)hept-2-en-2-carbonsaeurederivate und verfahren zu deren herstellung.
DE3667259D1 (de) Orientierte elastomerfolie und verfahren zu deren herstellung.
DE3782994D1 (de) Erythromycin-a-derivate und verfahren zu ihrer herstellung.
DE68917798D1 (de) Anschlussstruktur und Verfahren zu deren Herstellung.
DE3681938D1 (de) Halbleitersensor und verfahren zu seiner herstellung.
DE3686597D1 (de) Uricase und verfahren zu deren herstellung.
DE3782952D1 (de) Supraleitende dipolmagnete und verfahren zu deren herstellung.
DE3576931D1 (de) Mehrschichtstoffe und verfahren zu deren herstellung.
DE3862937D1 (de) 3-oxo-propannitril heteroarylderivate und verfahren zu deren herstellung.
DE3877709D1 (de) Indan-derivate und verfahren zu deren herstellung.
DE3685396D1 (de) Folie und verfahren zu deren herstellung.
DE3677740D1 (de) 2-iod-perfluor-2-methylalkane, verfahren zu deren herstellung und deren verwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Free format text: BARZ, P., DIPL.-CHEM. DR.RER.NAT., PAT.-ANW., 80803 MUENCHEN

8339 Ceased/non-payment of the annual fee